A Conserved Region of Leptospiral Immunoglobulin-Like A and B Proteins as a DNA Vaccine Elicits a Prophylactic Immune Response against Leptospirosis

American Society for Microbiology - Tập 20 Số 5 - Trang 725-731 - 2013
Karine Maciel Forster1, Daiane Drawanz Hartwig1, Fabiana K. Seixas1, Kátia Leston Bacelo1, Marta Gonçalves Amaral1, Cláudia Pinho Hartleben1, Odir Antônio Dellagostin1
1Núcleo de Biotecnologia, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, RS, Brazil

Tóm tắt

ABSTRACT

The leptospiral immunoglobulin-like (Lig) proteins LigA and LigB possess immunoglobulin-like domains with 90-amino-acid repeats and are adhesion molecules involved in pathogenicity. They are conserved in pathogenicLeptospiraspp. and thus are of interest for use as serodiagnostic antigens and in recombinant vaccine formulations. The N-terminal amino acid sequences of the LigA and LigB proteins are identical, but the C-terminal sequences vary. In this study, we evaluated the protective potential of five truncated forms of LigA and LigB proteins fromLeptospira interrogansserovar Canicola as DNA vaccines using the pTARGET mammalian expression vector. Hamsters immunized with the DNA vaccines were subjected to a heterologous challenge withL. interrogansserovar Copenhageni strain Spool via the intraperitoneal route. Immunization with a DNA vaccine encoding LigBrep resulted in the survival of 5/8 (62.5%) hamsters against lethal infection (P< 0.05). None of the control hamsters or animals immunized with the other vaccine preparations survived. The vaccine induced an IgG antibody response and, additionally, conferred sterilizing immunity in 80% of the surviving animals. Our results indicate that the LigBrep DNA vaccine is a promising candidate for inclusion in a protective leptospiral vaccine.

Từ khóa


Tài liệu tham khảo

Faine, 1999, Leptospira and leptospirosis, 2nd ed

Levett, 2001, Leptospirosis, Clin. Microbiol. Rev., 14, 296, 10.1128/CMR.14.2.296-326.2001

Reis, 2008, Impact of environment and social gradient on Leptospira infection in urban slums, PLoS Negl. Trop. Dis., 2, e228, 10.1371/journal.pntd.0000228

Hartskeerl, 2006, Leptospirosis: current status and future trends, Indian J. Med. Microbiol., 24, 309, 10.4103/0255-0857.29404

McBride, 2005, Leptospirosis, Curr. Opin. Infect. Dis., 18, 376, 10.1097/01.qco.0000178824.05715.2c

Bharti, 2003, Leptospirosis: a zoonotic disease of global importance, Lancet Infect. Dis., 3, 757, 10.1016/S1473-3099(03)00830-2

Lau, 2010, Leptospirosis: an emerging disease in travellers, Travel Med. Infect. Dis., 8, 33, 10.1016/j.tmaid.2009.12.002

Hartskeerl, 2011, Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world, Clin. Microbiol. Infect., 17, 494, 10.1111/j.1469-0691.2011.03474.x

Guitian, 1999, Infertility and abortion among first-lactation dairy cows seropositive or seronegative for Leptospira interrogans serovar hardjo, J. Am. Vet. Med. Assoc., 215, 515, 10.2460/javma.1999.215.04.515

Ko, 2009, Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen, Nat. Rev. Microbiol., 7, 736, 10.1038/nrmicro2208

Sonrier, 2000, Evidence of cross-protection within Leptospira interrogans in an experimental model, Vaccine, 19, 86, 10.1016/S0264-410X(00)00129-8

Koizumi, 2005, Leptospirosis vaccines: past, present, and future, J. Postgrad. Med., 51, 210

Cullen, 2004, Outer membrane proteins of pathogenic spirochetes, FEMS Microbiol. Rev., 28, 291, 10.1016/j.femsre.2003.10.004

Haake, 1999, Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection, Infect. Immun., 67, 6572, 10.1128/IAI.67.12.6572-6582.1999

Isberg, 1987, Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells, Cell, 50, 769, 10.1016/0092-8674(87)90335-7

Jerse, 1990, A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells, Proc. Natl. Acad. Sci. U. S. A., 87, 7839, 10.1073/pnas.87.20.7839

Dellagostin, 2011, Recombinant vaccines against leptospirosis, Hum. Vaccin., 7, 1215, 10.4161/hv.7.11.17944

Choy, 2007, Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen, Infect. Immun., 75, 2441, 10.1128/IAI.01635-06

Matsunaga, 2007, Osmotic regulation of expression of two extracellular matrix-binding proteins and a haemolysin of Leptospira interrogans: differential effects on LigA and Sph2 extracellular release, Microbiology, 153, 3390, 10.1099/mic.0.2007/007948-0

Matsunaga, 2005, Osmolarity, a key environmental signal controlling expression of leptospiral proteins LigA and LigB and the extracellular release of LigA, Infect. Immun., 73, 70, 10.1128/IAI.73.1.70-78.2005

Castiblanco-Valencia, 2012, Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP, J. Infect. Dis., 205, 995, 10.1093/infdis/jir875

Choy, 2012, Multiple activities of LigB potentiate virulence of Leptospira interrogans: inhibition of alternative and classical pathways of complement, PLoS One, 7, e41566, 10.1371/journal.pone.0041566

McBride, 2009, Genetic diversity of the leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp, Infect. Genet. Evol., 9, 196, 10.1016/j.meegid.2008.10.012

Silva, 2007, The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis, Vaccine, 25, 6277, 10.1016/j.vaccine.2007.05.053

Branger, 2005, Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1, Infect. Immun., 73, 4062, 10.1128/IAI.73.7.4062-4069.2005

Faisal, 2008, Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters, Vaccine, 26, 277, 10.1016/j.vaccine.2007.10.029

Ramos, 2004, A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide, Braz. J. Med. Biol. Res., 37, 1103, 10.1590/S0100-879X2004000800001

Seixas, 2007, Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge, Vaccine, 26, 88, 10.1016/j.vaccine.2007.10.052

Palaniappan, 2006, Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection, Infect. Immun., 74, 1745, 10.1128/IAI.74.3.1745-1750.2006

Yan, 2009, Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model, Microbes Infect., 11, 230, 10.1016/j.micinf.2008.11.008

Cao, 2011, Evaluation of novel fusion proteins derived from extracellular matrix binding domains of LigB as vaccine candidates against leptospirosis in a hamster model, Vaccine, 29, 7379, 10.1016/j.vaccine.2011.07.070

Coutinho, 2011, A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans, PLoS Negl. Trop. Dis., 5, e1422, 10.1371/journal.pntd.0001422

Kwissa, 2003, Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response, J. Mol. Med. (Berl.), 81, 502, 10.1007/s00109-003-0452-9

Wang, 2000, Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate, Vaccine, 18, 1227, 10.1016/S0264-410X(99)00391-6

Wolff, 1990, Direct gene transfer into mouse muscle in vivo, Science, 247, 1465, 10.1126/science.1690918

Matsunaga, 2003, Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily, Mol. Microbiol., 49, 929, 10.1046/j.1365-2958.2003.03619.x

Koizumi, 2004, Leptospiral immunoglobulin-like proteins elicit protective immunity, Vaccine, 22, 1545, 10.1016/j.vaccine.2003.10.007

Saade, 2012, Technologies for enhanced efficacy of DNA vaccines, Expert Rev. Vaccines, 11, 189, 10.1586/erv.11.188